/
CLVLF
$6.10-$0.30 (-4.69%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$6.10 – $8.60
0% from low
Exchange
OTC Link
OS
Price (6 mo)
Loading chart…
Change$-13.87
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $25.5M | $31.0M | $32.6M | $48.3M | $65.7M | $78.3M | $88.2M | $95.0M |
| Cost of revenue | $6.0M | $6.9M | $9.6M | $4.7M | $10.5M | $8.8M | $7.7M | $15.9M |
| Gross profit | $19.5M | $24.2M | $22.9M | $43.3M | $55.2M | $69.5M | $80.4M | $79.1M |
| Gross margin | 76.5% | 77.9% | 70.4% | 89.5% | 84.0% | 88.8% | 91.2% | 83.3% |
| R&D | $6.0M | $6.9M | $341.3K | $547.6K | $1.2M | $1.3M | $1.6M | $4.9M |
| Operating income | $12.1M | $18.1M | $13.2M | $29.4M | $36.1M | $44.9M | $48.0M | $45.7M |
| EBITDA | $12.3M | $18.4M | $13.6M | $28.2M | $37.4M | $49.6M | $56.3M | $57.2M |
| Net income | $13.2M | $18.1M | $16.6M | $24.7M | $20.9M | $30.6M | $35.6M | $36.2M |
| Net margin | 51.9% | 58.4% | 51.1% | 51.2% | 31.8% | 39.1% | 40.4% | 38.1% |
| EPS (diluted) | 0.27 | 0.37 | 0.30 | 0.48 | 0.40 | 0.59 | 0.70 | 0.72 |
Annual figures · source: Financial Modeling Prep
Analyst estimates (consensus)
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $99M | $0.71 | $0.67–$0.76 | 1 |
| 2027 | $105M | $0.75 | $0.71–$0.81 | 1 |
| 2028 | $123M | $1.09 | $1.02–$1.17 | 1 |
| 2029 | $429M | $4.50 | $4.25–$4.84 | 1 |
Forward consensus · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$13.40
Price
$6.10
Implied upside
+120%
Peer comparison
CLINUVEL PHARMS ORD
CLINUVEL PHARMS ORD
Held by traders on TradeandTell
No one on the platform currently holds CLVLF.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in CLVLF as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2010-11-12 | 1-for-10reverse |
Recent trades on TradeandTell
No one on the platform has traded CLVLF yet.